Why the study?
Do postprandial lipoprotein measurements improve discrimination of coronary heart disease compared to high-density-lipoprotein2 cholesterol or apolipoproteins B?
Population
Individuals with and without coronary heart disease
Comparison
Postprandial lipoprotein measurements vs Measurements of high-density-lipoprotein2…
Design
Review
Authors
Loading...
Postprandial lipoprotein measurements add negligible value for CHD discrimination; leaves open their role in refined risk models beyond HDL2 cholesterol or apolipoprotein B.
Do postprandial lipoprotein measurements improve discrimination of coronary heart disease compared to high-density-lipoprotein2 cholesterol or apolipoproteins B?
Postprandial lipoprotein measurements do not significantly improve the discrimination of coronary heart disease risk beyond standard lipid markers like HDL2 cholesterol and apolipoprotein B.
Peter Clifton (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: